Educational comparison - not medical advice. This page compares two compounds for informational purposes. Neither is recommended as treatment. Any protocol decision is a conversation with your licensed healthcare provider.
HGH (somatropin) is direct exogenous recombinant growth hormone - bypasses the pituitary entirely. Tesamorelin stimulates the pituitary to release endogenous GH. HGH produces larger and more predictable IGF-1 elevation but suppresses the natural axis, carries higher insulin-resistance risk, and has a greyer legal status. Tesamorelin preserves pulsatility and the body's feedback loops. Most optimization users prefer tesamorelin unless specifically indicated.
Informational only - neither compound is presented as a treatment for any condition. These are contexts in which users research these compounds and discuss them with their licensed provider.
Informational comparison only - not medical advice. Research-stage compounds discussed are not FDA-approved unless specifically noted. Any protocol decision should be made with a licensed healthcare provider.